WAVE LIFE SCIENCES LTD. Accounts Payable
WAVE LIFE SCIENCES LTD. (WVE) had Accounts Payable of $20.36 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-30
- 2026-06-30: Accounts Payable, Current $20.36M.
- 2026-03-31: Accounts Payable, Current $19.06M.
- 2025-12-31: Accounts Payable, Current $15.70M.
- 2025-09-30: Accounts Payable, Current $14.49M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $20.36M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $19.06M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $15.70M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $14.49M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $14.66M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $14.36M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.26M 10-K · filed 2026-02-26 |
| 2024-09-30 | $12.78M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $18.15M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.73M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $12.84M 10-K · filed 2025-03-04 |
| 2023-09-30 | $12.61M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $12.38M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $11.91M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $16.91M 10-K · filed 2024-03-06 |
| 2022-09-30 | $15.93M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $11.17M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $9.85M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $7.28M 10-K · filed 2023-03-23 |
| 2021-09-30 | $7.44M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $8.65M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $13.42M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $13.79M 10-K · filed 2022-03-03 |
| 2020-09-30 | $9.70M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.91M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $16.49M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.07M 10-K · filed 2021-03-04 |
| 2019-09-30 | $20.22M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $11.46M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $14.58M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $13.09M 10-K · filed 2020-03-02 |
| 2018-09-30 | $11.96M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $7.15M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $8.01M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $7.60M 10-K · filed 2019-03-01 |
| 2017-09-30 | $4.71M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $7.98M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $7.40M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.94M 10-K · filed 2018-03-12 |
| 2016-09-30 | $3.83M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.90M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.81M 10-K · filed 2017-03-16 |
| 2015-09-30 | $2.88M 10-Q · filed 2015-12-17 |
| 2014-12-31 | $125.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |